Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study

BACKGROUND: No study has performed a face-to-face comparison of biologics after the failure of the first anti-TNF agent in patients with Crohn’s disease (CD). The aim of the study was to compare the efficacy of biologics in this setting. METHODS: Patients with CD who were refractory to a first anti-...

Descripción completa

Detalles Bibliográficos
Autores principales: Cassandra, Rayer, Nachury, Maria, Arnaud, Bourreille, Xavier, Roblin, Laurent, Peyrin-Biroulet, Stephanie, Viennot, Mathurin, Flamant, David, Laharie, Bénédicte, Caron, Marie, Dewitte, Laurent, Siproudhis, Mathurin, Fumery, Guillaume, Bouguen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9717550/
https://www.ncbi.nlm.nih.gov/pubmed/36457080
http://dx.doi.org/10.1186/s12876-022-02583-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9717550/
https://www.ncbi.nlm.nih.gov/pubmed/36457080
http://dx.doi.org/10.1186/s12876-022-02583-5

Ejemplares similares